You Position: Home > Paper

Comparison of final adult height in boys with idiopathic short stature accepted growth hormone treatment or not

( views:48, downloads:156 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
Issue:
8
DOI:
10.3760/cma.j.issn.1008-6706.2011.08.005
Key Word:
特发性矮小;生长激素;最终成人身高;Growth hormone;Idiopathic short atature;Final adult height

Abstract: Objective In order to understand whether recombinant human growth hormone(r-hGH) can improve the idiopathic short stature(ISS) boys' final adult height(FAH).Methods We measured 16 cases diagnosed as ISS boys FAH, divided into 2 groups, of which 9 cases were not given r-hGH treatment, treatment group ,7 patients received r-hGH treatment, a dose of 0.1 ~ 0.13 U· kg-1·d-1, before going to sleep subcutaneous injection, duration of treatment was 6 ~ 20 months ( 11.9 ± 5.2 months).Results The treatment group compared with the average FAH FAH observation group had significantly improved the average(t =2.219,P<0.05).Conclusion r-hGH can improve the ISS boys FAH, but early treatment, the longer the course the more obvious effects.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn